BSC
LABU icon

BOLTON SECURITIES CORPORATION’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.14K Buy
+55
New +$9.03K ﹤0.01% 1639
2025
Q3 		$11.2K Buy
+120
New +$8.48K ﹤0.01% 1519
2025
Q1 		$4.88K Buy
+80
New +$6.82K ﹤0.01% 1591

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jump Financial
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
McGuire Investment Group
McGuire Investment Group Wakefield, Rhode Island $1.12B AUM 57.77% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $171B AUM 106.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's LABU Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026: 55 shares worth $9.14K. The stake represents ﹤0.01% of the portfolio and ranks #1639 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in LABU as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in LABU in Q1 2025 and has held it in 3 quarters since. The position peaked at $11.2K in Q3 2025. 34 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 55 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $9.14K as of Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1639 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $11.2K in Q3 2025.
  • 34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.